Gilles Jourquin

CEO of Newpharma

Gilles X. Jourquin, CEO of Newpharma, is an experienced leader in the pharmaceutical industry, with a focus on innovation and technology. He holds a PhD in Pharmacy from Université Libre de Bruxelles and a management degree from Solvay Business School. As CEO of the Newpharma Group since 2020, he has led initiatives in e-prescriptions, telemedicine, and digital health to improve customer experience and boost efficiency. Previously, he served as a board member and business leader at McKesson Belgium, overseeing global P&L, retail and wholesale operations, and the management of LloydsPharma S.A. and LloydsPharma Group S.A. His contributions have helped reshape the sector and advance the industry landscape.